Who gets ventilator priority?
Paper co-authored by MIT economist proposes a new way to handle medical shortages during the Covid-19 crisis.
Testing whether uncertified N95 masks are effective
Lincoln Laboratory joins MIT and others in testing N95 and similar, imported respirator masks to check how well they keep out particles and blood.
HIV genome bends over backwards to help virus take over cells
Differently shaped RNA molecules allow HIV to express different genes from the same RNA sequence.
An innovation plan to beat Covid-19
MIT economist Pierre Azoulay outlines a roadmap for scientific success against the virus.
MIT’s second virtual town hall addresses the months ahead
Decisions on when to return to campus await more information but may involve a phased process and continued precautions.
Q&A: Gregory Rutledge on initial testing of KN95 respirators for public health officials
MIT professor’s research group leverages its capability for testing filtration efficiency to assess certain respirators for MEMA, others.
3 Questions: Michael Yaffe on treating Covid-19 patients with acute respiratory distress
MIT professor and intensivist/trauma surgeon explains the new challenges that Covid-19 brings to treating patients in acute respiratory distress.
CRISPR-based diagnostic chips perform thousands of tests simultaneously to detect viruses
Diagnostic platform CARMEN combines microfluidics with CRISPR-based detection technology SHERLOCK, and could one day be used for public health efforts.
MIT conference reveals the power of using artificial intelligence to discover new drugs
Inaugural AI Powered Drug Discovery and Manufacturing Conference drew pharmaceutical companies, government regulators, and pioneering drug researchers.
Researchers identify cells likely targeted by Covid-19 virus
Study finds specific cells in the lungs, nasal passages, and intestines that are more susceptible to infection.
Q&A: Seth Mnookin on Covid-19 and the public understanding of science
MIT professor and writer examines the large-scale reaction to our new public health crisis.
Proteins may halt the severe cytokine storms seen in Covid-19 patients
Team designs antibody-like receptor proteins that can bind to cytokines, as possible strategy for treating coronavirus and other infections.
Model quantifies the impact of quarantine measures on Covid-19’s spread
A machine learning algorithm combines data on the disease's spread with a neural network, to help predict when infections will slow down in each country.
3 Questions: Catherine D’Ignazio on visualizing Covid-19 data
“Data scientists and visualization designers need to take their civic role very seriously in a pandemic,” says the MIT assistant professor.
3Q: Robert Macfarlane on cleaning your smartphone screen
Materials scientist explores why some household cleaners could harm the protective coating on a smartphone screen.